New clues to prostate cancer: Why aggressive subtype can resist treatment

Division of tongue tie: surgical complications
5 January 2021
Around 14.3 percent of U.S. population infected with SARS-CoV-2 by November 15
5 January 2021

New clues to prostate cancer: Why aggressive subtype can resist treatment

Australian research has identified a new mechanism in which prostate cancer cells can ‘switch’ character and become resistant to therapy.

Comments are closed.